Company intelligence / Profile preview

Azure Pharmaceuticals

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Azure Pharmaceuticals specializes in ensuring continued access to older, effective, and niche medicines—often generics—that may otherwise be unavailable or subject to supply interruptions. The company operates primarily in Ireland and Malta with a growing portfolio but does not appear to have novel clinical-stage assets or new molecular entities under development. Their business model centers on reintroducing established drugs rather than developing new ones.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Azure Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Azure Pharmaceuticals.

Explore the full profile